Dubaere, E, Goffaux, M, Bihin, B, Gheldof, C, Demoulin, A S, Bolly, A, Bustin, F, Duplaquet, F, Baugnee, P E, Gustin, M, Hers, V, Maisin, F, MARCHAND, ERIC, Ocak, S, Vancutsem, O, Van Neck, E, Wanet, M, Zaharia, L, Vandermoten, G, Van Esch, A & Remouchamps, V 2018, ' EP-1395 : Long term results and technology impact of 48 Gy SABR for inoperable peripheral stage I lung cancer ', Radiotherapy and Oncology, vol. 127, pp. S761-S762 . https://doi.org/10.1016/s0167-8140(18)31704-3
BMC Cancer BMC cancer, Vol. 19, no. 1, p. 639 [1-8] (2019) BMC Cancer, Vol 19, Iss 1, Pp 1-8 (2019) Dubaere, E, Goffaux, M, Wanet, M, Bihin, B, Gheldof, C, Demoulin, A-S, Bolly, A, Bustin, F, Duplaquet, F, Baugnee, P E, Gustin, M, Hers, V, Maisin, F, Marchand, É, Ocak, S, Pirard, L, Vancutsem, O, Van Neck, E, Vandermoten, G, Zaharia, L & Remouchamps, V 2019, ' Long term outcome after 48 Gy stereotactic ablative body radiotherapy for peripheral stage I non-small cell lung cancer ', BMC Cancer, vol. 19, no. 1, 328, pp. 639 . https://doi.org/10.1186/s12885-019-5863-2
Lung cancer: journal of the International Association for the Study of Lung Cancer Lung Cancer, 98, 118-121. Elsevier Ireland Ltd Europe PubMed Central Rosoux, A, Pauwels, P, Duplaquet, F, D'Haene, N, Weynand, B, Delos, M, Menon, R, Heukamp, L C, Thunnissen, E & Ocak, S 2016, ' Effectiveness of crizotinib in a patient with ALK IHC-positive/FISH-negative metastatic lung adenocarcinoma ', Lung Cancer, vol. 98, pp. 118-121 . https://doi.org/10.1016/j.lungcan.2016.06.001